Want to see SG:C8R full AI Analyst Report?
Top Page
Jiutian Chemical Group Limited
(SGX:C8R)
Select Model
Select Model
Rating:42Neutral
Price Target:
S$0.02
▼(-20.00% Downside)
Action:Reiterated
Date:08/25/26
The score is primarily held down by weak financial performance: recent years show collapsing revenue, deeply negative profitability (including negative gross profit), and negative operating/free cash flow. Technicals add pressure with the stock trading below key longer-term averages and only neutral-to-weak momentum signals. Valuation is not supportive because the negative P/E reflects losses, and no dividend yield is provided to offset risk.
Positive Factors
Moderate Leverage
Moderate and improving leverage provides some balance-sheet resilience. Debt remains below equity, which may limit financing strain and give the company more flexibility while it addresses operating losses and works toward business recovery.
Negative Factors
Collapsing Revenue
The sharp multi-year revenue contraction signals weakening demand, reduced scale, or lost business momentum. Persistently lower sales can impair fixed-cost absorption and make it harder for the company to restore margins and achieve sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Moderate Leverage
Moderate and improving leverage provides some balance-sheet resilience. Debt remains below equity, which may limit financing strain and give the company more flexibility while it addresses operating losses and works toward business recovery.
Read all positive factors
Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$33.80M
Dividend YieldN/A
Average Volume (3M)5.70M
Price to Earnings (P/E)―
Beta (1Y)1.31
Revenue Growth-69.91%
EPS Growth-13.56%
CountrySG
Employees200
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.09
Shares Outstanding1,988,444,000
10 Day Avg. Volume2,600,530
30 Day Avg. Volume5,701,756
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.71
Price to Sales (P/S)2.49
P/FCF Ratio-1.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jiutian Chemical Group Limited Business Overview & Revenue Model
Company Description
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio enc...
How the Company Makes Money
null...
Jiutian Chemical Group Limited Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
45
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 393.13M | 108.43M | 243.76M | 598.56M | 2.43B | 2.17B |
| Gross Profit | -147.20M | -108.72M | -82.26M | -260.18M | 708.41M | 675.62M |
| EBITDA | -141.98M | -101.49M | -118.22M | -321.76M | 696.61M | 517.79M |
| Net Income | -162.31M | -239.63M | -147.80M | -344.64M | 490.50M | 324.90M |
Balance Sheet | ||||||
| Total Assets | 1.42B | 626.61M | 1.05B | 1.29B | 1.99B | 1.89B |
| Cash, Cash Equivalents and Short-Term Investments | 698.48M | 198.16M | 400.41M | 529.62M | 1.11B | 773.55M |
| Total Debt | 234.88M | 127.62M | 289.32M | 265.88M | 134.64M | 228.18M |
| Total Liabilities | 469.16M | 248.45M | 427.02M | 523.23M | 764.65M | 1.08B |
| Stockholders Equity | 948.17M | 378.31M | 618.04M | 765.84M | 1.22B | 816.21M |
Cash Flow | ||||||
| Free Cash Flow | -356.18M | -155.06M | -171.63M | -511.23M | 424.05M | 633.54M |
| Operating Cash Flow | -328.39M | -129.87M | -81.58M | -385.65M | 434.01M | 655.81M |
| Investing Cash Flow | -27.72M | -24.57M | -89.54M | -125.70M | -9.85M | -27.68M |
| Financing Cash Flow | -53.04M | -160.50M | 32.87M | -732.00K | -95.52M | -110.89M |
Jiutian Chemical Group Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Negative
48.11
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.11 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C8R.
Jiutian Chemical Group Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | S$640.53M | 8.17 | 9.08% | 4.40% | 4.17% | -12.40% | |
65 Neutral | S$45.19M | -4.17 | -10.15% | 0.92% | -7.25% | 95.72% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
45 Neutral | S$10.36M | -8.75 | -79.63% | ― | ― | ― | |
42 Neutral | S$33.80M | -0.75 | -48.10% | ― | -69.91% | -13.56% | |
39 Underperform | S$11.35M | -1.58 | -72.32% | ― | 25.81% | -30.34% |
* Basic Materials Sector Average
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-34.62%
SG:QES
China Sunsine Chemical Holdings Ltd.
0.66
-0.05
-6.52%
SG:C05
Chemical Industries Far East Ltd.
0.60
0.05
9.17%
SG:M15
Matex International Limited
0.02
0.00
0.00%
SG:5DS
MegaChem Ltd.
0.52
0.11
26.83%
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
Jiutian Chemical Group Limited Corporate Events
Jiutian Chemical Cleared of Liability as Arbitration Claim Withdrawn
Aug 11, 2026
Jiutian Chemical Group Limited has announced that an arbitration claim filed against the company at the Shanghai International Economic and Trade Arbitration Commission has been withdrawn by the claimant. The arbitral tribunal accepted the withdra...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.